Found 20 matching trials
The Associations of Plasminogen Activator Inhibitor-1 Gene Polymorphisms With Crohn's Disease in Chinese Patients
N/AFrom January 2020 to January 2025, Crohn's disease (CD) patients and gender...
Location
the Second Affiliated Hospital of Wenzhou Medical University
Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease
PHASE2To determine whether treatment with ustekinumab will alter the ratio of T R...
Location
H. Lee Moffitt Cancer Center & Research Institute
SIIT Based on UST CDST in Patients With CD
PHASE4ustekinumab (UST) can effectively induce and maintain clinical remission an...
The Association Between TNFSF4 Polymorphism and CD
N/AThe goal of this observational study is to investigate the associations bet...
Location
the Second Affiliated Hospital of Wenzhou Medical University
A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease
PHASE3The primary purpose of this study is to evaluate the efficacy and safety of...
Location
University of California, San Diego
The PODIUM Study - a Three-arm Comparison of Target Therapies After Anti-TNFα in Ulcerative Colitis
N/AThe goal of this observational study is to compare the real-life effectiven...
Location
Humanitas Research Hospital IRCSS
A Study on the Associations Between Microribonucleic Acid Gene Polymorphisms and Crohn's Disease
N/AFrom January 2020 to January 2025, Crohn's disease (CD) patients and gender...
Location
the Second Affiliated Hospital of Wenzhou Medical University
Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease
N/AThis study intends to select patients with confirmed moderate-to-severe Cro...
Location
Second Affiliated Hospital, School of Medicine, Zhejiang University
NAZA - Nottingham/Astra ZenecA Prospective IBD Cohort Study
N/AThe goal of this observational study is to learn about the comparisons of i...
Location
University of Nottingham
A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease
PHASE2This study is open to adults, aged 18-75 years, with moderate to severe Cro...
Location
California Medical Research Associates Inc.